University Of Notre Dame Du Lac Alnylam Pharmaceuticals, Inc. Transaction History

University Of Notre Dame Du Lac

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$65.86 - $92.79 $2.05 Million - $2.89 Million	-31,101 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$72.76 - $93.45 $79,744 - $102,421	-1,096 Reduced 3.4%	31,101 $2.91 Million
Q4 2018 Feb 13, 2019	BUY	$62.67 - $88.33 $148,590 - $209,430	2,371 Added 7.95%	32,197 $2.35 Million
Q3 2018 Nov 13, 2018	BUY	$87.52 - $122.67 $251,532 - $352,553	2,874 Added 10.66%	29,826 $2.61 Million
Q2 2018 Aug 14, 2018	BUY	$88.31 - $107.8 $425,830 - $519,811	4,822 Added 21.79%	26,952 $2.66 Million
Q1 2018 May 15, 2018	BUY	$115.92 - $148.54 $235,897 - $302,278	2,035 Added 10.13%	22,130 $2.64 Million
Q4 2017 Feb 13, 2018	SELL	$114.49 - $139.98 $1.35 Million - $1.65 Million	-11,802 Reduced 37.0%	20,095 $2.55 Million
Q3 2017 Nov 13, 2017	BUY	$72.53 - $118.27 $2.31 Million - $3.77 Million	31,897	31,897 $3.75 Million

642

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $30.1B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of University Of Notre Dame Du Lac, based on Form 13F filings with the SEC.

Stay updated on University Of Notre Dame Du Lac with notifications on news.